CVKD Form 4: Quang Pham disposes 500 shares under 10b5-1 plan
Rhea-AI Filing Summary
Cadrenal Therapeutics, Inc. (CVKD) director, CEO and chairman Quang Pham reported a planned sale of 500 shares of common stock executed on 10/02/2025 under a Rule 10b5-1 trading arrangement at prices ranging from $14.04 to $14.27, with a weighted average price of $14.13. Following the transaction, Mr. Pham directly owns 202,133 shares and indirectly holds 200,000 shares through The PVBQ Living Trust, for which he is trustee and retains sole voting and dispositive power. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Positive
- Sale executed under a documented Rule 10b5-1 plan, indicating a pre‑arranged, compliant trading program
- Full disclosure of direct and indirect holdings: 202,133 direct shares and 200,000 indirect via The PVBQ Living Trust
Negative
- Disposition of 500 shares reduces direct holdings (though the change is small relative to total ownership)
- Form signed by attorney-in-fact rather than the reporting person (signature dated 10/03/2025)
Insights
TL;DR: Sale executed under a Rule 10b5-1 plan; reporting shows ongoing disclosure compliance.
The filing states the 500-share sale was made pursuant to a documented 10b5-1 trading arrangement, which provides the reporting person an affirmative defense to insider trading claims when executed properly. The report discloses both direct and indirect holdings—202,133 direct and 200,000 indirect—clarifying control and beneficiary details for The PVBQ Living Trust.
This level of disclosure aligns with standard Section 16 reporting practices and aids transparency about insider ownership and intent.
TL;DR: The trade is small relative to holdings; no material change to ownership stakes is shown.
The reported disposition of 500 shares at a weighted average of $14.13 represents a de minimis reduction versus the disclosed combined beneficial ownership of 402,133 shares. The price range ($14.04–$14.27) is provided, but the filer notes that detailed per-price quantities are available upon request.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 500 | $14.13 | $7K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $14.04 through $14.27, inclusive, having a weighted average price as shown in column 4 of $14.13. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and disposition power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.
